127 related articles for article (PubMed ID: 19504451)
1. [Quantitative pyrosequencing of heterozygous single nucleotide polymorphisms for rapid diagnosis of Down's syndrome].
Liu XQ; Wu HP; Bu Y; Zou BJ; Chen ZY; Zhou GH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):331-5. PubMed ID: 19504451
[TBL] [Abstract][Full Text] [Related]
2. [Development of 3-enzyme pyrosequencing system and its application in rapid diagnosis of Down's syndrome].
Liu XQ; Zhu SH; Zou BJ; Ma YJ; Zhou GH
Yi Chuan; 2010 May; 32(5):517-23. PubMed ID: 20466643
[TBL] [Abstract][Full Text] [Related]
3. [Use of quantitative fluorescence polymerase chain reaction in the invasive prenatal diagnosis of Down's syndrome].
Kriventsova NV; Shokarev RA; Avrutskaia VV; Kriger SIu; Klochkova NE; Gimbut VS; Kornienko IV
Klin Lab Diagn; 2010 Aug; (8):27-30. PubMed ID: 20891040
[TBL] [Abstract][Full Text] [Related]
4. [Rapid prenatal diagnosis of Down's syndrome in the first trimester of pregnancy by fluorescence in situ hybridization].
Xiang Y; Sun N; Wang F
Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):646-8. PubMed ID: 9639761
[TBL] [Abstract][Full Text] [Related]
5. Prenatal diagnosis of trisomy 21 by quantitatively pyrosequencing heterozygotes using amniotic fluid as starting material of PCR.
Ye H; Wu H; Huang H; Liu Y; Zou B; Sun L; Zhou G
Analyst; 2013 Apr; 138(8):2443-8. PubMed ID: 23463136
[TBL] [Abstract][Full Text] [Related]
6. Rapid testing versus karyotyping in Down's syndrome screening: cost-effectiveness and detection of clinically significant chromosome abnormalities.
Gekas J; van den Berg DG; Durand A; Vallée M; Wildschut HI; Bujold E; Forest JC; Rousseau F; Reinharz D
Eur J Hum Genet; 2011 Jan; 19(1):3-9. PubMed ID: 20842178
[TBL] [Abstract][Full Text] [Related]
7. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
[TBL] [Abstract][Full Text] [Related]
8. Rapid molecular method for prenatal detection of Down's syndrome.
Pertl B; Yau SC; Sherlock J; Davies AF; Mathew CG; Adinolfi M
Lancet; 1994 May; 343(8907):1197-8. PubMed ID: 7909872
[TBL] [Abstract][Full Text] [Related]
9. Rapid detection of Down's syndrome using quantitative real-time PCR (qPCR) targeting segmental duplications on chromosomes 21 and 11.
Sun L; Fan Z; Weng X; Ye X; Long J; Fu K; Yan S; Wang B; Zhuo Y; Liu X; Lao K
Gene; 2014 Dec; 552(2):272-6. PubMed ID: 25256276
[TBL] [Abstract][Full Text] [Related]
10. Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units.
Chitty LS; Wright D; Hill M; Verhoef TI; Daley R; Lewis C; Mason S; McKay F; Jenkins L; Howarth A; Cameron L; McEwan A; Fisher J; Kroese M; Morris S
BMJ; 2016 Jul; 354():i3426. PubMed ID: 27378786
[TBL] [Abstract][Full Text] [Related]
11. A prospective clinical trial to compare the performance of dried blood spots prenatal screening for Down's syndrome with conventional non-invasive testing technology.
Hu H; Jiang Y; Zhang M; Liu S; Hao N; Zhou J; Liu J; Zhang X; Ma L
Exp Biol Med (Maywood); 2017 Mar; 242(5):547-553. PubMed ID: 28056555
[TBL] [Abstract][Full Text] [Related]
12. Prenatal genetic services for Down's syndrome: access and provision in 1990-1991. Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
Williamson P; Harris R; Church S; Fiddler M; Rhind J
Br J Obstet Gynaecol; 1996 Jul; 103(7):676-83. PubMed ID: 8688395
[TBL] [Abstract][Full Text] [Related]
13. Expression of chromosome 21 specific sequences in normal and Down's syndrome tissues.
Stefani L; Galt J; Palmer A; Affara N; Ferguson-Smith M; Nevin NC
Nucleic Acids Res; 1988 Apr; 16(7):2885-96. PubMed ID: 2966929
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive prenatal diagnosis of Down syndrome in samples from Southwest Chinese gravidas using pregnant plasma placental RNA allelic ratio.
Zhang Y; Liu H; Chen X; Xie X; Liu S; Wang H
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1051-7. PubMed ID: 22924494
[TBL] [Abstract][Full Text] [Related]
15. [A study on population-based prenatal screening and diagnosis of Down's syndrome in Jiangsu province].
Liu QL; Hu YL; Xu ZF; Wang LJ; Sun Q; Lin N; Xu XY; Liu Y; Zhang JW; Tong JS; Wang XH; He J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Jun; 27(3):340-2. PubMed ID: 20533279
[TBL] [Abstract][Full Text] [Related]
16. Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment.
Caine A; Maltby AE; Parkin CA; Waters JJ; Crolla JA;
Lancet; 2005 Jul 9-15; 366(9480):123-8. PubMed ID: 16005334
[TBL] [Abstract][Full Text] [Related]
17. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy].
Yu DY; Fu P; Zhang ZH; Wang F; Han MY; Ren HY; Zhao W; Zhang K; Li S; Jiang N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):332-5. PubMed ID: 21644235
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnosis of Down's syndrome.
Wang S; Jia C; Ren G; Ma Y; Lü W; Ding F; Han J
Chin Med J (Engl); 2003 Nov; 116(11):1773-5. PubMed ID: 14642158
[TBL] [Abstract][Full Text] [Related]
20. Prenatal screening for Down's syndrome with use of maternal serum markers.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
